Cosmo Pharmaceuticals appoints Chief Strategy Officer (Cosmo Pharmaceuticals)

Cosmo Pharmaceuticals N.V. has announced the appointment of Dominika Spilarova as its Chief Strategy Officer, effective January 10, 2025. Dominika, a seasoned strategist with over 15 years of experience across the Life Sciences sector and management consulting, will drive growth and innovation strategies at Cosmo. She will also temporarily serve as acting Chief of Staff for the executive leadership team.